Compare · MGRX vs PARK
MGRX vs PARK
Side-by-side comparison of Mangoceuticals Inc. (MGRX) and Park Dental Partners Inc. (PARK): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MGRX and PARK operate in Misc Health and Biotechnology Services (Health Care), so they compete in similar markets.
- PARK is the larger of the two at $84.7M, about 9.5x MGRX ($8.9M).
- Over the past year, MGRX is down 68.7% and PARK is up 84.6% - PARK leads by 153.3 points.
- Both names hit the wire about 1 times in the past 4 weeks.
- PARK has more recent analyst coverage (2 ratings vs 0 for MGRX).
PerformanceMGRX-56.08%PARK+84.57%
2025-12-03+0.00%2026-07-24
- Company
- Mangoceuticals Inc.
- Park Dental Partners Inc.
- Price
- $0.54-3.14%
- $19.38-1.72%
- Market cap
- $8.9M
- $84.7M
- 1M return
- +59.53%
- +8.75%
- 1Y return
- -68.74%
- +84.57%
- Industry
- Misc Health and Biotechnology Services
- Misc Health and Biotechnology Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2023
- 2025
- News (4w)
- 1
- 1
- Recent ratings
- 0
- 2
Latest MGRX
- SEC Form S-8 filed by Mangoceuticals Inc.
- Mangoceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
- SEC Form 10-Q filed by Mangoceuticals Inc.
- SEC Form NT 10-Q filed by Mangoceuticals Inc.
- SEC Form 10-K filed by Mangoceuticals Inc.
- SEC Form NT 10-K filed by Mangoceuticals Inc.
- SEC Form 4 filed by Cohen Jacob D.
- SEC Form 4 filed by Cohen Jacob D.
- Mangoceuticals Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc.
Latest PARK
- Park Dental Partners Announces Dates for Second Quarter 2026 Earnings Release and Conference Call
- SEC Form 4 filed by Director Smith Philip Irving
- SEC Form 4 filed by CEO and Chairman Swenson Peter G
- SEC Form 4 filed by Officer Steele Christopher Eugene
- SEC Form 4 filed by Director Smith Christopher Charles
- SEC Form 4 filed by Chief Financial Officer Bernander Christopher James
- SEC Form 4 filed by Director Schaefer Anna Marie
- SEC Form 4 filed by Officer Law Alan Siems
- Amendment: SEC Form SCHEDULE 13G/A filed by Park Dental Partners Inc.
- Park Dental Partners Expands Presence in Rochester, Minn., with Addition of Zumbro View Dental